caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760431852

Joel MaxM.D.

DermatologyTimonium, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
4,684
Unique beneficiaries
—
Total services
7,528
Distinct HCPCS
29
Medicare payment
$348K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 262 Dermatology providers in MD — top quintile (cohort median 2,654).
REFERRAL NETWORK

Where Joel Max's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 41 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
160361
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
147255
BETHESDA DERMATOPATHOLOGY LAB INC.125187
Cohen Dermatopathology, P.C.
Clinical Laboratory · Needham, MA
125429
UNIVERSITY OF MARYLAND ST. JOSEPH MEDICAL CENTER, LLC5587
GREATER BALTIMORE MEDICAL CENTER, INC.5184
William Tan
Internal Medicine · Eldersburg, MD
3371
ALPHA CLINICAL LABORATORIES, LLC3177
SINAI HOSPITAL OF BALTIMORE, INC.2531
Amit Narula
Pulmonary Disease · Westminster, MD
2560
Maria Goldman
Nurse Practitioner · Westminster, MD
2443
SCHERR, STUART2347
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
81.3
Quality
66.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.27%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
1,179
Beneficiaries
—
Total drug cost
$695K
Distinct drugs
32
Brand share
21.5%
Top prescribed drugs
Triamcinolone Acetonide135 claims
Betamethasone Dipropionate108 claims
Dupilumab96 claims
Clobetasol Propionate94 claims
Tacrolimus85 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$371
Payment records
17
By payment type
Education$186
Food and Beverage$185
Top paying entities
Education$186
Food and Beverage$185